SARS-coronavirus vaccine - AlphaVax
Alternative Names: Coronavirus vaccine - AlphaVax; SARS vaccine - AlphaVaxLatest Information Update: 28 Jul 2022
Price :
$50 *
At a glance
- Originator AlphaVax
- Class Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Coronavirus infections
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for preclinical development in Coronavirus-infections(Prevention) in USA
- 24 Jul 2020 SARS coronavirus vaccine is still in preclinical development for Coronavirus-infections (Prevention) in USA (AlphaVax pipeline, July 2020)
- 28 Dec 2019 No recent reports of development identified for preclinical development in Coronavirus-infections in USA